| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 223.39 mm | 223.39 mm | 223.39 mm | 223.39 mm | 223.39 mm | 223.39 mm |
| Cash burn (monthly) | 3.37 mm | 841.75 k | 4.63 mm | 8.34 mm | (no burn) | 102.08 k |
| Cash used (since last report) | 14.34 mm | 3.59 mm | 19.72 mm | 35.50 mm | n/a | 434.79 k |
| Cash remaining | 209.05 mm | 219.81 mm | 203.68 mm | 187.89 mm | n/a | 222.96 mm |
| Runway (months of cash) | 62.1 | 261.1 | 44.0 | 22.5 | n/a | 2184.1 |
| 13F holders | Current |
|---|---|
| Total holders | 184 |
| Opened positions | 36 |
| Closed positions | 18 |
| Increased positions | 75 |
| Reduced positions | 43 |
| 13F shares | Current |
|---|---|
| Total value | 1.95 tn |
| Total shares | 64.04 mm |
| Total puts | 167.30 k |
| Total calls | 177.20 k |
| Total put/call ratio | 0.9 |
| Largest owners | Shares | Value |
|---|---|---|
| Frazier Life Sciences Management | 6.57 mm | $256.25 bn |
| JHG Janus Henderson | 4.48 mm | $174.74 bn |
| Frazier Life Sciences IX | 3.57 mm | $94.27 mm |
| Eventide Asset Managment | 3.45 mm | $134.37 bn |
| BlackRock | 3.37 mm | $131.36 bn |
| Biotechnology Value Fund L P | 3.08 mm | $120.51 mm |
| BVF | 3.08 mm | $119.96 bn |
| Vanguard | 2.50 mm | $97.35 bn |
| New Enterprise Associates 16 | 2.19 mm | $65.78 mm |
| STT State Street | 1.79 mm | $69.96 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Feb 25 | Radovich Peter | Common Stock | Sell | Dispose S | No | No | 48.2226 | 2,627 | 126.68 k | 26,961 |
| 3 Feb 25 | Christopher Peetz | Common Stock | Sell | Dispose S | No | No | 48.2225 | 9,102 | 438.92 k | 115,920 |
| 3 Feb 25 | Jolanda Howe | Common Stock | Sell | Dispose S | No | No | 48.2225 | 1,064 | 51.31 k | 4,232 |
| 31 Jan 25 | Jolanda Howe | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,772 | 0.00 | 5,296 |
| 31 Jan 25 | Jolanda Howe | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 1,772 | 0.00 | 1,771 |
| 24 Jan 25 | Christopher Peetz | Common Stock | Sell | Dispose S | No | No | 47.9243 | 6,837 | 327.66 k | 125,022 |
| 24 Jan 25 | Jolanda Howe | Common Stock | Sell | Dispose S | No | No | 47.9244 | 902 | 43.23 k | 3,524 |
| 23 Jan 25 | Christopher Peetz | Common Stock | Option exercise | Acquire M | No | No | 0 | 12,500 | 0.00 | 131,859 |
| 23 Jan 25 | Christopher Peetz | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 12,500 | 0.00 | 25,000 |
| 23 Jan 25 | Jolanda Howe | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,500 | 0.00 | 4,426 |
